Endoscopic Submucosal Dissection Market

Endoscopic Submucosal Dissection Market Outlook (2024 to 2034)

The endoscopic submucosal dissection market size is estimated to be valued at US$ 313.0 million in 2024. Projections indicate a remarkable expansion with a CAGR of 7.40% through 2034. Anticipated growth is set to propel the market to an impressive size of US$ 640.5 million by 2034. Increasing demand for minimally invasive procedures and advancements in endoscopic technology have driven the market growth for the ESD testing market.

The endoscopic submucosal dissection industry generated an estimated revenue of US$ 216.4 million in 2019. In five years, the market grew at a pace of 7.66% CAGR and added a revenue of US$ 96.60 million.

• Rising prevalence of gastrointestinal disorders, such as colorectal cancer and gastric tumors in the general population all over the world
• Minimally invasive nature of ESD procedure compared to traditional surgical methods, leading to reduced patient discomfort, shorter hospital stays, and quicker recovery times
• Ongoing advancements in endoscopic technology, including improved imaging capabilities and precision tools, enhancing the efficacy and safety of ESD procedures
• Growing emphasis on early detection and treatment of gastrointestinal lesions for precisely removing lesions at an early stage, reducing the risk of disease progression
• The growing aging global population creates a larger patient pool for ESD procedures
• Greater awareness among healthcare professionals and patients about the benefits of ESD, coupled with educational initiatives
• Improvements in reimbursement policies for endoscopic procedures and access to advanced medical technologies

Apart from these factors, several others have contributed to the remarkable expansion of the endoscopic submucosal dissection market. Supportive government initiatives aimed at promoting advanced medical procedures and technologies are also one of the main factors driving the growth of the endoscopic submucosal dissection market. Investments in healthcare infrastructure, by private as well as public healthcare institutes, have also created a conducive environment for the growth of ESD.

Report Attributes	Details
Estimated Market Value (2024E)	US$ 313.0 million
Forecasted Market Value (2034F)	US$ 640.5 million
Global Market Growth Rate (2024 to 2034)	7.40% CAGR
Stomach Cancer Segment Growth Rate (2024 to 2034)	7.60%
Hospital Segment Growth Rate (2024 to 2034)	7.10%
North America Market Share (2024)	10.0%
East Asia Market Share (2024)	56.90%
Key Companies Profiled	Erbe Elektromedizin GmbH Sumitomo Bakelite Co., Ltd. Ovesco Endoscopy AG FUJIFILM Holdings Corporation Olympus Corporation Boston Scientific Corporation ZEON CORPORATION COOK Group ConMed Steris

Which Factors Have Driven the Global Surge for Endoscopic Submucosal Dissection Demand?

“Rising Incidences of Gastrointestinal Diseases, especially Colorectal Cancer and Gastric Tumors to Amplify Growth”

Unhealthy dietary habits, sedentary lifestyles, and an aging population have significantly increased the cases related to gastrointestinal diseases. This has driven a heightened demand for advanced and effective treatment options like endoscopic submucosal dissection (ESD). As these diseases are often diagnosed at advanced stages, there is a growing emphasis on early detection and intervention.

ESD, being a minimally invasive procedure, allows for the precise removal of lesions at an early stage, reducing the risk of disease progression. This nature of ESD in comparison to traditional surgical methods is one of the main reasons why people are increasingly preferring it over other methods. Also, patients undergoing ESD experience less trauma to surrounding tissues. This not only enhances the overall patient experience but also reduces healthcare costs associated with prolonged hospitalization.

“Growing Aging Population and Ongoing Technological Advancements in Endoscopic Equipment to Play an Important Part”

The growing aging population globally has also contributed to the increasing prevalence of gastrointestinal diseases. The geriatric demographic is more susceptible to conditions such as colorectal cancer and other gastrointestinal disorders. ESD procedures are generally less painful and require less recovery time as compared to traditional treatments which involve surgery and prolonged hospitalization. This is why, there is a great demand for ESD in the elderly population all over the world.

Ongoing technological advancements in endoscopic equipment have also played a pivotal role in the growth of the ESD market. Endoscopic equipment with improved imaging capabilities and enhanced efficiency have elevated the reliance of the general population on ESD for their gastrointestinal disorders. All these factors have collectively contributed to the growth of ESD market in the medicare industry.

Which Factors Present Challenges to the Expansion of the Endoscopic Submucosal Dissection Market?

“Procedural Complexity, High Initial Equipment Costs, and Limited Accessibility to Slow down Market Growth”

In countries with limited infrastructure development in the medicare industry, finding a skilled workforce for operating technically complex ESD equipment is one of the biggest challenges. Laboratories and hospitals have to invest a substantial amount of financial resources in training the staff. For smaller facilities with a limited budget, this can be a serious setback. Besides this, advanced endoscopic equipment for ESD is expensive. Clinics and hospitals may find this kind of investment heavy in countries with less government support. These factors have led to a slowdown in the ESD market all over the world.

Country-wise Insights

The East Asian endoscopic submucosal dissection market is poised for exceptional growth, projecting a modest CAGR of 7.5% through 2034. The surge is primarily attributed to increasing demand for endoscopic submucosal dissection in key countries, notably China and Japan. In 2024, Japan dominates the endoscopic submucosal dissection industry with an estimated 47.7% market share. Meanwhile, the North American endoscopic submucosal dissection market is anticipated to exhibit substantial progress, aiming for an 8.9% CAGR in 2024. In this region, the United States emerges as the key player in the industry, commanding a significant share of 88.4% in 2024.

Why is Japan Leading the Endoscopic Submucosal Dissection Market in the East Asian Region?

“Early Adoption and Extensive Experience in Endoscopic Submucosal Dissection to Augment Market Growth”

The East Asian market stood at US$ 178 million in 2024, acquiring a revenue share of 56.90%, and is further projected to expand at a CAGR of 7.5% through 2034. The Japanese endoscopic submucosal dissection industry is estimated to be worth US$ 85 million in 2024. The demand for endoscopic submucosal dissection in Japan is projected to rise at a CAGR of 7.4% through 2034.

Japan is one of the first countries to have developed and adopted ESD procedures, due to its advanced medicare sector. This early adoption led to well-established training programs and widespread expertise among healthcare professionals for the successful integration of ESD into clinical practice. Apart from this, Japan is also dealing with a growing aging population which is more susceptible to gastrointestinal disorders. This has also contributed considerably to the ESD market in the region.

Why is the United States Commanding the North American Endoscopic Submucosal Dissection Market?

“Increasing Prevalence of Gastrointestinal Diseases Associated with Sedentary Lifestyles to Help Market Expansion”

The United States’ endoscopic submucosal dissection industry is estimated to be worth US$ 28 million in 2024, garnering a share of 88.4% in the North American region. The sales of endoscopic submucosal dissection are likely to record a CAGR of 8.9% through 2034.

The adoption of sedentary lifestyles in East Asian countries has led to a rise in conditions such as colorectal cancer and gastric tumors. Gastrointestinal disorders generally arise due to reduced physical activity and the consumption of processed and high-calorie diets. As these lifestyle-related health issues become more prevalent, the demand for advanced and minimally invasive treatments like ESD is very likely to surge in the North American region.

Category-wise Insights

The stomach cancer segment is estimated to hold an 81.40% market share in 2024 based on the indication. Simultaneously, the hospitals segment is anticipated to secure a noteworthy 44.5% share, contributing significantly to the market's resource diversity and stability. Based on end-users, the ambulatory segment marks its dominance in the endoscopic submucosal dissection industry, with a share of 33.8% in 2024.

How does Endoscopic Submucosal Dissection Help Detect Stomach Cancer?

“Enhanced Precision and Early Detection Builds Trust in the General Population”

Endoscopic Submucosal Dissection (ESD) plays a crucial role in the detection and treatment of stomach cancer. The demand for ESD in the medicare sector has skyrocketed in recent years as it allows the identification and removal of abnormal growths, such as precancerous lesions or early-stage tumors, precisely. This precision of ESD enables healthcare professionals to obtain larger tissue samples for accurate histopathological examination, aiding in the definitive diagnosis of stomach cancer.

This ability of ESD to facilitate early diagnosis and treatment of stomach cancer contributes significantly to the growth in demand for this technique. As awareness of the importance of early detection continues to rise, both among healthcare providers and the general population, there is a greater emphasis on employing minimally invasive procedures like ESD.

Competitive Landscape

The endoscopic submucosal dissection market globally is filled with a multitude of companies, such as Erbe Elektromedizin GmbH, Sumitomo Bakelite Co., Ltd., Ovesco Endoscopy AG, FUJIFILM Holdings Corporation, Olympus Corporation, etc. These companies are some of the most prominent ones in the medicare industry. They have a substantial amount of loyal consumer base which consists of hospitals, clinics, and laboratories. There is a considerable number of small companies, too, in the market. These companies usually cater to the demands of regional entities and heavily rely on the innovations of industry giants due to scarce financial resources for research and development.

• On March 10, 2023, Agilis Robotics Ltd. completed its first mainland China test, validating the feasibility and versatility of its robotic instruments for endoscopic surgery. Surgeons simulated training and successfully performed endoscopic submucosal dissection and en bloc resection of a bladder tumor. Top of Form
• On February 28, 2023, Mediclinic Parkview Hospital launched endoscopic submucosal dissection (ESD) services, offering a less invasive alternative for patients who would have otherwise needed surgical interventions, such as esophageal, colon, or stomach resection.
• In January 2023, Fujifilm expanded its endoscopy solutions with the launch of ClutchCutter and FushKnife, presented at the 63rd Annual Conference of the Indian Society of Gastroenterology-ISGCON in Jaipur.

Key Segments Covered in Endoscopic Submucosal Dissection Industry

• Endoscopic Submucosal Dissection Market by Product:

  • Knives
  • Tissue Retractors
  • Grasp/Clips
  • Injecting Agents
  • Gastroscopes & Colonoscopes

• Endoscopic Submucosal Dissection Market by Indication:

  • Esophageal Cancer
  • Stomach Cancer
  • Colon Cancer

• Endoscopic Submucosal Dissection Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Speciality Clinics

• By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa